Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern.

Skelly DT., Harding AC., Gilbert-Jaramillo J., Knight ML., Longet S., Anthony Brown None., Adele S., Adland E., Brown H., Team ML., Tom Tipton None., Stafford L., Johnson SA., Amini A., Group OPTICC., Kit Tan T., Schimanski L., Huang K-YA., Rijal P., Group PITCHS., Group CP-C., Frater J., Goulder P., Conlon CP., Jeffery K., Dold C., Pollard AJ., Townsend AR., Klenerman P., Dunachie SJ., Barnes E., Carroll MW., James WS.

DOI

10.21203/rs.3.rs-226857/v1

Type

Preprint

Publication Date

09/02/2021

Permalink Original publication